These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
239 related articles for article (PubMed ID: 9125494)
41. Variability of the canonical loop conformations in serine proteinases inhibitors and other proteins. Apostoluk W; Otlewski J Proteins; 1998 Sep; 32(4):459-74. PubMed ID: 9726416 [TBL] [Abstract][Full Text] [Related]
42. Elafin and its precursor trappin-2 still inhibit neutrophil serine proteinases when they are covalently bound to extracellular matrix proteins by tissue transglutaminase. Guyot N; Zani ML; Maurel MC; Dallet-Choisy S; Moreau T Biochemistry; 2005 Nov; 44(47):15610-8. PubMed ID: 16300411 [TBL] [Abstract][Full Text] [Related]
43. Release and degradation of angiotensin I and angiotensin II from angiotensinogen by neutrophil serine proteinases. Ramaha A; Patston PA Arch Biochem Biophys; 2002 Jan; 397(1):77-83. PubMed ID: 11747312 [TBL] [Abstract][Full Text] [Related]
44. 13C- and 1H-NMR studies of oxyanion and tetrahedral intermediate stabilization by the serine proteinases: optimizing inhibitor warhead specificity and potency by studying the inhibition of the serine proteinases by peptide-derived chloromethane and glyoxal inhibitors. Malthouse JP Biochem Soc Trans; 2007 Jun; 35(Pt 3):566-70. PubMed ID: 17511653 [TBL] [Abstract][Full Text] [Related]
45. Use of the 1,2,5-thiadiazolidin-3-one 1,1 dioxide and isothiazolidin-3-one 1,1 dioxide scaffolds in the design of potent inhibitors of serine proteinases. Kuang R; Venkataraman R; Ruan S; Groutas WC Bioorg Med Chem Lett; 1998 Mar; 8(5):539-44. PubMed ID: 9871614 [TBL] [Abstract][Full Text] [Related]
46. [High molecular weight soy isoinhibitors of the Bowman-Birk type. Isolation, characteristics, and kinetics of interaction with proteinases]. Gladysheva IP; Sharafutdinov TZ; Larionova NI Bioorg Khim; 1994 Mar; 20(3):281-9. PubMed ID: 8166755 [TBL] [Abstract][Full Text] [Related]
47. Inhibition of neutrophil cathepsin G by oxidized mucus proteinase inhibitor. Effect of heparin. Boudier C; Cadène M; Bieth JG Biochemistry; 1999 Jun; 38(26):8451-7. PubMed ID: 10387091 [TBL] [Abstract][Full Text] [Related]
48. Inhibition of murine neutrophil serine proteinases by human and murine secretory leukocyte protease inhibitor. Wright CD; Kennedy JA; Zitnik RJ; Kashem MA Biochem Biophys Res Commun; 1999 Jan; 254(3):614-7. PubMed ID: 9920787 [TBL] [Abstract][Full Text] [Related]
49. Substituted 3-(phenylsulfonyl)-1-phenylimidazolidine-2,4-dione derivatives as novel nonpeptide inhibitors of human heart chymase. Niwata S; Fukami H; Sumida M; Ito A; Kakutani S; Saitoh M; Suzuki K; Imoto M; Shibata H; Imajo S; Kiso Y; Tanaka T; Nakazato H; Ishihara T; Takai S; Yamamoto D; Shiota N; Miyazaki M; Okunishi H; Kinoshita A; Urata H; Arakawa K J Med Chem; 1997 Jul; 40(14):2156-63. PubMed ID: 9216834 [TBL] [Abstract][Full Text] [Related]
50. Crystal structure of bovine duodenase, a serine protease, with dual trypsin and chymotrypsin-like specificities. Pletnev VZ; Zamolodchikova TS; Pangborn WA; Duax WL Proteins; 2000 Oct; 41(1):8-16. PubMed ID: 10944388 [TBL] [Abstract][Full Text] [Related]
51. Structure of porcine pancreatic elastase complexed with FR901277, a novel macrocyclic inhibitor of elastases, at 1.6 A resolution. Nakanishi I; Kinoshita T; Sato A; Tada T Biopolymers; 2000 Apr; 53(5):434-45. PubMed ID: 10738204 [TBL] [Abstract][Full Text] [Related]
52. The 2.2 A crystal structure of human chymase in complex with succinyl-Ala-Ala-Pro-Phe-chloromethylketone: structural explanation for its dipeptidyl carboxypeptidase specificity. Pereira PJ; Wang ZM; Rubin H; Huber R; Bode W; Schechter NM; Strobl S J Mol Biol; 1999 Feb; 286(1):163-73. PubMed ID: 9931257 [TBL] [Abstract][Full Text] [Related]
53. Rapid inactivation of alpha-1-proteinase inhibitor by neutrophil specific leukolysin/membrane-type matrix metalloproteinase 6. Nie J; Pei D Exp Cell Res; 2004 Jun; 296(2):145-50. PubMed ID: 15149845 [TBL] [Abstract][Full Text] [Related]
54. 7-alkylidenecephalosporin esters as inhibitors of human leukocyte elastase. Buynak JD; Rao AS; Ford GP; Carver C; Adam G; Geng B; Bachmann B; Shobassy S; Lackey S J Med Chem; 1997 Oct; 40(21):3423-33. PubMed ID: 9341917 [TBL] [Abstract][Full Text] [Related]
55. Inhibition of human leukocyte proteinase 3 by a novel recombinant serine proteinase inhibitor (LEX032). Groutas WC; Ruan S; Kuang R; Hook JB; Sands H Biochem Biophys Res Commun; 1997 Apr; 233(3):697-9. PubMed ID: 9168917 [TBL] [Abstract][Full Text] [Related]
56. Interscaffolding additivity. Association of P1 variants of eglin c and of turkey ovomucoid third domain with serine proteinases. Qasim MA; Ganz PJ; Saunders CW; Bateman KS; James MN; Laskowski M Biochemistry; 1997 Feb; 36(7):1598-607. PubMed ID: 9048543 [TBL] [Abstract][Full Text] [Related]
57. Inhibition of human serine proteases by substituted 2-azetidinones. Knight WB; Chabin R; Green B Arch Biochem Biophys; 1992 Aug; 296(2):704-8. PubMed ID: 1632655 [TBL] [Abstract][Full Text] [Related]
58. The Gabriel-Colman rearrangement in biological systems: design, synthesis and biological evaluation of phthalimide and saccharin derivatives as potential mechanism-based inhibitors of human leukocyte elastase, cathepsin G and proteinase 3. Groutas WC; Chong LS; Venkataraman R; Epp JB; Kuang R; Houser-Archield N; Hoidal JR Bioorg Med Chem; 1995 Feb; 3(2):187-93. PubMed ID: 7796053 [TBL] [Abstract][Full Text] [Related]
59. Inhibition of neutrophil serine proteinases by suramin. Cadène M; Duranton J; North A; Si-Tahar M; Chignard M; Bieth JG J Biol Chem; 1997 Apr; 272(15):9950-5. PubMed ID: 9092534 [TBL] [Abstract][Full Text] [Related]